Vimarsana
Biggest News Aggregation in the World

Page 34 - Solutions Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solutions Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solutions Inc Today - Breaking & Trending Today

VIQ Solutions (TSE:VQS) Stock Price Down 6.5% - Vimarsana News

VIQ Solutions (TSE:VQS) Stock Price Down 6.5%

VIQ Solutions Inc. (TSE:VQS – Get Free Report) fell 6.5% during trading on Tuesday . The company traded as low as C$0.21 and last traded at C$0.22. 31,400 shares changed hands during mid-day trading, a decline of 37% from the average session volume of 50,094 shares. The stock had previously closed at C$0.23. VIQ Solutions […]

Source: wkrb13.com
ResMed Inc. Forecasted to Earn Q2 2025 Earnings of $2.10 Per Share (NYSE:RMD) - Vimarsana News

ResMed Inc. Forecasted to Earn Q2 2025 Earnings of $2.10 Per Share (NYSE:RMD)

ResMed Inc. (NYSE:RMD – Free Report) – Investment analysts at Zacks Research lifted their Q2 2025 earnings estimates for ResMed in a research report issued to clients and investors on Monday, May 27th. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings per share of $2.10 for the quarter, […]

Citigroup Reaffirms "Neutral" Rating for Kenvue (NYSE:KVUE) - Vimarsana News

Citigroup Reaffirms "Neutral" Rating for Kenvue (NYSE:KVUE)

Citigroup restated their neutral rating on shares of Kenvue (NYSE:KVUE – Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage currently has a $21.00 target price on the stock. KVUE has been the topic of several other research reports. Royal Bank of Canada cut their price target on […]

Corcept Therapeutics (NASDAQ:CORT) Stock Rating Reaffirmed by HC Wainwright - Vimarsana News

Corcept Therapeutics (NASDAQ:CORT) Stock Rating Reaffirmed by HC Wainwright

Corcept Therapeutics (NASDAQ:CORT – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued on Wednesday, Benzinga reports. They presently have a $40.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 28.16% from the stock’s current […]

Danaos (NYSE:DAC) Price Target Raised to $105.00 - Vimarsana News

Danaos (NYSE:DAC) Price Target Raised to $105.00

Danaos (NYSE:DAC – Free Report) had its target price raised by Jefferies Financial Group from $90.00 to $105.00 in a report issued on Tuesday morning, Benzinga reports. Jefferies Financial Group currently has a buy rating on the shipping company’s stock. Danaos Stock Performance DAC opened at $94.13 on Tuesday. The company has a current ratio […]